| Breakdown | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2022 | Mar 2020 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 977.90M | 1.19B | 3.97B | 3.59B | 2.72B |
| Gross Profit | 81.15M | 152.04M | 450.69M | 437.90M | 264.64M |
| EBITDA | -97.21M | -83.33M | -61.22M | 90.39M | -32.87M |
| Net Income | -130.72M | -111.36M | -94.71M | 44.97M | -7.13M |
Balance Sheet | |||||
| Total Assets | 1.70B | 1.47B | 2.04B | 2.92B | 2.67B |
| Cash, Cash Equivalents and Short-Term Investments | 63.65M | 53.56M | 271.52M | 109.50M | 74.00M |
| Total Debt | 879.44M | 571.90M | 961.29M | 1.69B | 1.46B |
| Total Liabilities | 1.35B | 983.59M | 1.38B | 2.09B | 1.87B |
| Stockholders Equity | 504.57M | 610.74M | 751.68M | 872.16M | 829.56M |
Cash Flow | |||||
| Free Cash Flow | -240.09M | 248.94M | 669.97M | -157.45M | -229.31M |
| Operating Cash Flow | -204.29M | 251.04M | 675.55M | -153.37M | -225.95M |
| Investing Cash Flow | -79.31M | -55.52M | -4.32M | -2.90M | 3.24M |
| Financing Cash Flow | 289.85M | -408.19M | -506.49M | 191.36M | 94.67M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
71 Outperform | HK$375.00M | 12.59 | 5.48% | 0.78% | 5.43% | -25.42% | |
63 Neutral | HK$1.05B | 1.71 | 10.38% | 5.38% | -6.58% | 16.23% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
60 Neutral | HK$108.00M | 1.61 | 11.07% | ― | 37.73% | 150.54% | |
43 Neutral | HK$109.93M | 1.70 | -20.08% | ― | 75.21% | 18.42% | |
42 Neutral | HK$1.02B | -1.31 | -37.13% | ― | 42.14% | -81.25% | |
40 Underperform | HK$166.10M | -0.77 | ― | ― | -6.04% | -340.00% |